Keros Therapeutics (KROS)
NASDAQ:KROS
US Market
Holding KROS?
Track your performance easily

Keros Therapeutics (KROS) Cash flow

230 Followers

Keros Therapeutics Cash Flow

KROS's free cash flow for Q2 2024 was $-40.11M. For the 2024 fiscal year, KROS's free cash flow was decreased by $-55.67M and operating cash flow was $-39.80M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -143.80M$ -124.51M$ -70.06M$ -62.15M$ -36.89M$ -16.00M
Investing Cash Flow
$ -2.35M$ -2.46M$ -1.24M$ -1.02M$ -294.00K$ -271.00K
Financing Cash Flow
$ 229.87M$ 178.96M$ 120.31M$ 28.55M$ 296.04M$ 14.00K
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 1.35B$ 280.38M$ 231.37M$ 231.37M$ 7.13M$ 7.13M
Income Tax Paid Supplemental Data
-----$ 256.00K
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
$ 151.34M---$ 102.67M$ 0.00
Issuance Of Debt
------
Repayment Of Debt
------
Free Cash Flow
$ -120.15M$ -126.97M$ -71.30M$ -63.17M$ -37.19M$ -16.27M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Keros Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis